Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new…
- M. K. Pasha, S. Muzeeb, S. J. S. Basha, D. Shashikumar, R. Mullangi, N. Srinivas
- Chemistry, Medicine
- Biomedical chromatography : BMC
- 1 March 2006
A specific, accurate, precise and reproducible high-performance liquid chromatographic (HPLC) method was developed and validated for the simultaneous quantitation of five 3-hydroxy-3-methyglutaryl… Expand
Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.
- Sanjita Sasmal, D. Balasubrahmanyam, +18 authors T. Hoegberg
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 1 May 2012
Melanin concentrating hormone receptor 1 (MCHR1) antagonists have potential for the treatment of obesity and several CNS disorders. In the preceding article, we have described a novel series of… Expand
Performance Evaluation of Smart Antenna DOA Estimation using MUSIC & Improved MUSIC algorithms
- Sharanya Vaidyanath, Dhanya Shashikumar
- Engineering
- 7 April 2015
Array signal processing deals with the manipulation of signals for null steering to reduce interference and to point the major lobe towards the intended signal. High Resolution signal processing… Expand
- 1
- 1
Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and for qualitative…
- S. J. S. Basha, S. A. Naveed, +8 authors N. Srinivas
- Chemistry, Medicine
- Journal of chromatography. B, Analytical…
- 15 June 2007
Simultaneous separation and quantification of ezetimibe (EZM) and its phase-I metabolite i.e., ezetimibe ketone (EZM-K) and phase-II metabolite i.e., ezetimibe glucuronide (EZM-G) in various matrices… Expand
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administration.
- Thomas Ullrich, Sanjita Sasmal, +19 authors H. Keller
- Chemistry, Medicine
- Journal of medicinal chemistry
- 26 August 2014
We describe the synthesis and characterization of 3-alkoxy-pyrrolo[1,2-b]pyrazolines as novel selective androgen receptor (AR) modulators that possess excellent physicochemical properties for… Expand
Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Focus to detune hERG inhibition
- P. K. Sasmal, Sanjita Sasmal, +14 authors T. Hoegberg
- Chemistry
- 1 May 2011
Melanin concentrating hormone receptor 1 (MCHR1) antagonists are potentially useful in the treatment of several CNS disorders such as obesity, stress, depression and anxiety. In a previous article,… Expand
Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
- Sanjita Sasmal, G. Balaji, +16 authors T. Hoegberg
- Medicine
- Bioorganic & medicinal chemistry letters
- 2012
Melanin concentrating hormone (MCH) is an important mediator of energy homeostasis and plays a role in metabolic and CNS disorders. The modeling-supported design, synthesis and multi-parameter… Expand
Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): Role of…
- S. Muzeeb, S. J. S. Basha, D. Shashikumar, R. Mullangi, N. Srinivas
- Biology, Medicine
- European Journal of Drug Metabolism and…
- 1 October 2006
SummaryDRF-4367 is a novel COX-2 inhibitor, which showed good efficacy in several animal models of inflammation. In a comparative in vitro metabolism in various liver microsomes, DRF-4367 forms a… Expand